Bhardwaj R, Moore P K
Department of Pharmacology, King's College, University of London, UK.
J Pharm Pharmacol. 1988 Oct;40(10):739-42. doi: 10.1111/j.2042-7158.1988.tb07009.x.
The vasodilator effect of acetylcholine (ACh) and nitroprusside and the vasoconstrictor effect of noradrenaline was assessed in the perfused kidney of streptozocin diabetic rats. Compared with control animals injected with acidified saline, the renal vasoconstrictor effect of noradrenaline was increased in diabetic rats both in terms of the dose required to produce 50% of the maximal effect (EC50) and in the maximal response achieved. The renal vasodilator effect of ACh (but not nitroprusside) was similarly enhanced in diabetic animals. The effect of ACh (but not nitroprusside) in the perfused kidney of both control and diabetic rats was reduced or abolished by mepacrine (10 microM), metyrapone (10 microM) or methylene blue (100 microM) suggesting that ACh exhibits vasodilator activity in the rat kidney by virtue of releasing endothelium derived relaxing factor (EDRF). These results are in contrast to previous published reports demonstrating reduced biosynthesis of EDRF in the aorta of diabetic rats. The mechanism which underlies the increased renal vascular response to ACh is not known. However, increased endothelial cell turnover or cholinoceptor number, elevated activity of enzyme(s) which synthesis EDRF or hyperresponsiveness of vascular smooth muscle to released EDRF should all be considered.
在链脲佐菌素诱导的糖尿病大鼠的灌注肾中评估了乙酰胆碱(ACh)和硝普钠的血管舒张作用以及去甲肾上腺素的血管收缩作用。与注射酸化生理盐水的对照动物相比,糖尿病大鼠中去甲肾上腺素的肾血管收缩作用在产生最大效应的50%所需剂量(EC50)和所达到的最大反应方面均增强。糖尿病动物中ACh(而非硝普钠)的肾血管舒张作用同样增强。在对照和糖尿病大鼠的灌注肾中,ACh(而非硝普钠)的作用被米帕林(10 microM)、甲吡酮(10 microM)或亚甲蓝(100 microM)减弱或消除,这表明ACh通过释放内皮源性舒张因子(EDRF)在大鼠肾脏中发挥血管舒张活性。这些结果与先前发表的报道相反,那些报道显示糖尿病大鼠主动脉中EDRF的生物合成减少。ACh引起的肾血管反应增加的机制尚不清楚。然而,内皮细胞更新增加或胆碱受体数量增加、合成EDRF的酶活性升高或血管平滑肌对释放的EDRF反应性增强都应予以考虑。